The trading price of Evolent Health Inc (NYSE:EVH) closed higher on Tuesday, January 21, and closing at $10.17, 1.70% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $9.9124 and $10.26. In examining the 52-week price action we see that the stock hit a 52-week high of $35.00 and a 52-week low of $9.88. Over the past month, the stock has lost -6.44% in value.
Evolent Health Inc, whose market valuation is $1.19 billion at the time of this writing, is expected to release its quarterly earnings report in February. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest EVH has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned EVH a recommendation rating is 5. Out of them, 0 rate it a Hold, while 5 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Evolent Health Inc (EVH) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that EVH’s price is currently -10.09% off the SMA20 and -17.22% off the SMA50. The RSI metric on the 14-day chart is currently showing 34.70, and weekly volatility stands at 9.19%. When measured over the past 30 days, the indicator reaches 5.88%. Evolent Health Inc (NYSE:EVH)’s beta value is currently sitting at 1.45, while the Average True Range indicator is currently displaying 0.74. With analysts defining $14-$38 as the low and high price targets, we arrive at a consensus price target of $19 for the trailing 12-month period. The current price is about -37.66% off the estimated low and -273.65% off the forecast high, based on this estimate. Investors will be thrilled if EVH’s share price rises to $19, which is the median consensus price. At that level, EVH’s share price would be -86.82% below current price.
To see how Evolent Health Inc stock has been performing in comparison to its peers in the industry, here are the numbers: EVH stock’s performance was 1.70% in the latest trading, and -65.92% in the past year.
An evaluation of the daily trading volume of Evolent Health Inc (NYSE:EVH) indicates that the 3-month average is 2.75 million. However, this figure has increased over the past 10 days to an average of 2.74.
Currently, records show that 115.01 million of the company’s shares remain outstanding. The insiders hold 3.28% of outstanding shares, whereas institutions hold 110.94%. The stats also highlight that short interest as of 2024-12-31, stood at 10.19 million shares, resulting in a short ratio of 4.24 at that time. From this, we can conclude that short interest is 1011.00 of the company’s total outstanding shares. It is noteworthy that short shares in December were down slightly from the previous month’s figure, which was 10.51 million. However, since the stock’s price has seen -9.60% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
